Ixazomib enhances the antitumor effect of brigatinib in TP53 -mutated EML4-ALK lung cancer cells. // JAAD International. – URL: https://www.sciencedirect.com/science/article/pii/S3117504X26000483?dgcid=rss_sd_all
Ixazomib enhances the antitumor effect of brigatinib in TP53 -mutated EML4-ALK lung cancer cells. JAAD International. https://www.sciencedirect.com/science/article/pii/S3117504X26000483?dgcid=rss_sd_all
“Ixazomib enhances the antitumor effect of brigatinib in TP53 -mutated EML4-ALK lung cancer cells.” JAAD International.
@article{article5819,
title = {Ixazomib enhances the antitumor effect of brigatinib in TP53 -mutated EML4-ALK lung cancer cells},
journal = {JAAD International},
url = {https://www.sciencedirect.com/science/article/pii/S3117504X26000483?dgcid=rss_sd_all}
}